参考文献/References:
[1] WANG M,CHEN P,JIA Y,et al.Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma[J].Oncotarget,2015,6(20):17958-17967.
[2] 张之南,沈悌.血液病诊断及疗效标准[M].北京:科学技术出版社,2007:232-234.
[3] 袁媛,李金娇,肖荦,等.Ann Arbor分期划分淋巴瘤淋巴结区域的意义探讨[J].中国现代医学杂志,2017,27(10):107-111.
[4] 韩效林,李敬东,王婉玲,等.多发性骨髓瘤患者骨髓中调节性性T细胞/辅助性T细胞17比值及其与临床指标的关系[J].新乡医学院学报,2017,34(6):384-388.
[5] 李炳宗,庄文卓,陈萍,等.多发性骨髓瘤患者骨髓间充质干细胞免疫调节功能异常及其在骨髓瘤骨病中的作用[J].中华微生物学和免疫学杂志,2010,30(9): 853-859.
[6] JOSHUA D,SUEN H,BROWN R,et al.The T cell in myeloma clin lymphoma myeloma[J].Leuk,2016,16(10):537-542.
[7] 费远丽,高文,杨光.不同移植方式对小鼠恶性黑色素移植瘤的生长及其血管生成的影响[J].眼科新进展,2015,35(4):326-329.
[8] 张苗,张秀莲,张伟华,等.多发性骨髓瘤骨病患者白细胞介素-17 的表达及其意义[J].白血病·淋巴瘤,2012,21(5):282-284.
[9] PRABHALA R H,PELLURU D,FULCINITI M,et al.Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma[J].Blood,2010,115(26):5385-5392.
[10] 张耀,宋路茜,张曦,等.多发性骨髓瘤患者外周血Th17细胞功能研究[J].中国实验血液学杂志,2013,21(5):1187-1189.
[11] 杨云,何爱丽,王剑利,等.沙利度胺对多发性骨髓瘤患者外周血Th17细胞影响的研究[J].中国实验血液学杂志,2015,23(5):1341-1345.
[12] LEE Y,JUNG J I,PARK K Y,et al.Synergistic inhibition effect of TNIK inhibitor KY-05009 and receptor tyrosine kinase inhibitor dovitinib on IL-6-induced proliferation and Wnt signaling pathway in human multiple myeloma cells[J].Oncotarget,2017,8(25):41091-41101.
相似文献/References:
[1]赵媛英,楼风冈.不分泌型多发性骨髓瘤染色体改变——附一例报告[J].新乡医学院学报,1984,1(02):041.
[2]王双琳,王慧睿,肖蓬莉,等.多发性骨髓瘤细胞中ZNF382甲基化状态及其意义[J].新乡医学院学报,2020,37(7):611.[doi:10.7683/xxyxyxb.2020.07.003]
WANG Shuanglin,WANG Huirui,XIAO Pengli,et al.Significance of ZNF382 methylation in multiple myeloma cells[J].Journal of Xinxiang Medical University,2020,37(2):611.[doi:10.7683/xxyxyxb.2020.07.003]
[3]杨 翠,李敬东,王婉玲,等.CUEDC2与多发性骨髓瘤细胞糖皮质激素敏感性的相关性[J].新乡医学院学报,2019,36(12):1125.[doi:10.7683/xxyxyxb.2019.12.006]
YANG Cui,LI Jing-dong,WANG Wan-ling,et al.Correlation between CUEDC2 and glucocorticoid sensitivity in multiple myeloma cells[J].Journal of Xinxiang Medical University,2019,36(2):1125.[doi:10.7683/xxyxyxb.2019.12.006]
[4]余海青,李敏婕,郑美芳.甲钴胺对硼替佐米所致多发性骨髓瘤患者周围神经病变的防治效果[J].新乡医学院学报,2018,35(7):620.[doi:10.7683/xxyxyxb.2018.07.018]
YU Hai-qing,LI Min-jie,ZHENG Mei-fang.Preventive effect of mecobalamin on peripheral neuropathy induced by bortezomib in patients with multiple myeloma[J].Journal of Xinxiang Medical University,2018,35(2):620.[doi:10.7683/xxyxyxb.2018.07.018]
[5]韩效林,李敬东,王婉玲,等.多发性骨髓瘤患者骨髓中调节性T细胞/辅助性T细胞17比值及其与临床指标的关系[J].新乡医学院学报,2017,34(6):485.[doi:10.7683/xxyxyxb.2017.06.008]
HAN Xiao-lin,LI Jing-dong,WANG Wan-ling,et al.Treg/Th17 ratio in patients with multiple myeloma and its relationship with clinical parameters[J].Journal of Xinxiang Medical University,2017,34(2):485.[doi:10.7683/xxyxyxb.2017.06.008]